These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2859126)
21. Hepatic N-acetyltransferases: selective inactivation in vivo by a carcinogenic N-arylhydroxamic acid. Smith TJ; Hanna PE Biochem Pharmacol; 1988 Feb; 37(3):427-34. PubMed ID: 3257389 [TBL] [Abstract][Full Text] [Related]
22. Modulation of the embryotoxicity and cytotoxicity elicited by 7-hydroxy-2-acetylaminofluorene and acetaminophen via deacetylation. Stark KL; Harris C; Juchau MR Toxicol Appl Pharmacol; 1989 Mar; 97(3):548-60. PubMed ID: 2609350 [TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives. Jacobs MM; Matney TS; Griffin AC Cancer Lett; 1977 May; 2(6):319-22. PubMed ID: 324608 [TBL] [Abstract][Full Text] [Related]
24. Prevention by thioethers of the hepatotoxicity and covalent binding to macromolecules of N-hydroxy-2-acetylaminofluorene and its sulfate ester in rat liver in vivo and in vitro. van den Goorbergh JA; de Wit H; Tijdens RB; Mulder GJ; Meerman JH Carcinogenesis; 1987 Feb; 8(2):275-9. PubMed ID: 2433070 [TBL] [Abstract][Full Text] [Related]
25. Correlation between clastogenicity and promotion activity in liver carcinogenesis by N-hydroxy-2-acetylaminofluorene, N-hydroxy-4'-fluoro-4-acetylaminobiphenyl and N-hydroxy-4-acetylaminobiphenyl. van de Poll ML; van der Hulst DA; Tates AD; Meerman JH Carcinogenesis; 1990 Feb; 11(2):333-9. PubMed ID: 2302760 [TBL] [Abstract][Full Text] [Related]
26. Elevation of hepatic microsomal epoxide hydrolase activity by 2-acetylaminofluorene: strain and species differences. Graichen ME; Dent JG Carcinogenesis; 1984 Jan; 5(1):23-8. PubMed ID: 6690083 [TBL] [Abstract][Full Text] [Related]
27. Comparative toxicity and mutagenicity of N-hydroxy-2-acetylaminofluorene and 7-acetyl-N-hydroxy-2-acetylaminofluorene in human lymphoblasts. Babson JR; Gavitt NE; Boteju LW; Hanna PE Mutat Res; 1992 Sep; 269(1):73-8. PubMed ID: 1381473 [TBL] [Abstract][Full Text] [Related]
28. Reductase activity of aldehyde oxidase toward the carcinogen N-hydroxy-2-acetylaminofluorene and the related hydroxamic acids. Kitamura S; Sugihara K; Tatsumi K Biochem Mol Biol Int; 1994 Dec; 34(6):1197-203. PubMed ID: 7696992 [TBL] [Abstract][Full Text] [Related]
29. Activation of N-acetoxy- and N-hydroxy-2-acetylaminofluorene to mutagenic and cytotoxic metabolites by V79 Chinese hamster cells. Glatt H; Oesch F Mutat Res; 1985 Apr; 149(2):265-9. PubMed ID: 3885026 [TBL] [Abstract][Full Text] [Related]
30. N- and O-deacetylation of N-acetoxy-N-arylacetamides by mammalian hepatic microsomes. Yamada H; Lee MS; Wang CY Carcinogenesis; 1988 Nov; 9(11):1995-2002. PubMed ID: 3180338 [TBL] [Abstract][Full Text] [Related]
31. The role of acetylator genotype on hepatic and extrahepatic acetylation, deacetylation, and sulfation of 2-aminofluorene, 2-acetylaminofluorene, and N-hydroxy-2-acetylaminofluorene in the inbred hamster. Hein DW; Kirlin WG; Ogolla F; Trinidad A; Thompson LK; Ferguson RJ Drug Metab Dispos; 1986; 14(5):566-73. PubMed ID: 2876863 [TBL] [Abstract][Full Text] [Related]
32. The role of N-sulfation in the N-hydroxy-2-acetylaminofluorene-mediated outgrowth of diethylnitrosamine-initiated hepatocytes to gamma-glutamyltranspeptidase-positive foci in male rat liver. Kroese ED; van de Poll ML; Mulder GJ; Meerman JH Carcinogenesis; 1988 Nov; 9(11):1953-8. PubMed ID: 2902938 [TBL] [Abstract][Full Text] [Related]
33. Purification and characterization of rat hepatic microsomal N,O-acyltransferases. Wang CY; Zukowski K; Lee MS; Sone T Carcinogenesis; 1992 Nov; 13(11):2017-20. PubMed ID: 1423870 [TBL] [Abstract][Full Text] [Related]
34. Metabolism of 2-acetylaminofluorene. I. Metabolism in vitro of 2-acetylaminofluorene and 2-acetylaminofluoren-9-one by hepatic enzymes. Lenk W; Rosenbauer-Thilmann R Xenobiotica; 1993 Mar; 23(3):241-57. PubMed ID: 8498087 [TBL] [Abstract][Full Text] [Related]
35. Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538. Weeks CE; Allaben WT; Tresp NM; Louie SC; Lazear EJ; King CM Cancer Res; 1980 Apr; 40(4):1204-11. PubMed ID: 6986982 [No Abstract] [Full Text] [Related]
36. Pseudoenzymatic reduction of N-hydroxy-2-acetylaminofluorene to 2-acetylaminofluorene mediated by cytochrome P450. Kitamura S; Takekawa K; Sugihara K; Tatsumi K; Ohta S Carcinogenesis; 1999 Feb; 20(2):347-50. PubMed ID: 10069476 [TBL] [Abstract][Full Text] [Related]
37. Irreversible inhibition of rat hepatic transacetylase activity by N-arylhydroxamic acids. Wick MJ; Jantan IB; Hanna PE Biochem Pharmacol; 1988 Apr; 37(7):1225-31. PubMed ID: 3355596 [TBL] [Abstract][Full Text] [Related]
38. Elevation of hepatic microsomal epoxide hydrolase activity by 2-acetylaminofluorene: role of metabolism. Graichen ME; Dent JG Carcinogenesis; 1985 Jul; 6(7):977-81. PubMed ID: 4017177 [TBL] [Abstract][Full Text] [Related]
39. Genetic variability in deacetylation of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in inbred strains of mice. Hultin TA; Weber WW Carcinogenesis; 1987 Dec; 8(12):1939-41. PubMed ID: 3677317 [TBL] [Abstract][Full Text] [Related]
40. The role of specific DNA adducts in the induction of micronuclei by N-hydroxy-2-acetylaminofluorene in rat liver in vivo. van de Poll ML; van der Hulst DA; Tates AD; Mulder GJ; Meerman JH Carcinogenesis; 1989 Apr; 10(4):717-22. PubMed ID: 2702720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]